BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 15051747)

  • 21. Diabetic dyslipidemia: effects of diabetes control, diet and drug therapy.
    Bar-On H
    Isr J Med Sci; 1996 Jun; 32(6):397-406. PubMed ID: 8682645
    [No Abstract]   [Full Text] [Related]  

  • 22. Epidemiology of diabetes.
    Winer N; Sowers JR
    J Clin Pharmacol; 2004 Apr; 44(4):397-405. PubMed ID: 15051748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economics of diabetes mellitus.
    Krein SL; Funnell MM; Piette JD
    Nurs Clin North Am; 2006 Dec; 41(4):499-511, v-vi. PubMed ID: 17059971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Economic costs of diabetes mellitus: critical review and cost-benefit evaluation of proposed strategies for its reduction].
    Rubio JA; Alvarez J
    Aten Primaria; 1998 Sep; 22(4):239-55. PubMed ID: 9803577
    [No Abstract]   [Full Text] [Related]  

  • 25. [Dietary management of lipid disorders. Plant oil protects hearts of diabetic patients].
    MMW Fortschr Med; 2003 Oct; 145(41):51. PubMed ID: 14655490
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pathogenesis of atherosclerosis in diabetes mellitus].
    Pozzati A; Abrignani MG
    Ital Heart J; 2004 Apr; 5 Suppl 4():7S-11S. PubMed ID: 15185471
    [No Abstract]   [Full Text] [Related]  

  • 27. [Diabetic dyslipidemia].
    Izhakov E; Rubinstein A
    Harefuah; 2001 Jul; 140(7):632-3. PubMed ID: 11481969
    [No Abstract]   [Full Text] [Related]  

  • 28. The treatment of hypertension and dyslipidemia in diabetes mellitus.
    Fineberg SE
    Prim Care; 1999 Dec; 26(4):951-64. PubMed ID: 10523469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hypertension and diabetes mellitus].
    Mehnert H; Kuhlmann H
    Dtsch Med J; 1968 Aug; 19(16):567-71. PubMed ID: 5702732
    [No Abstract]   [Full Text] [Related]  

  • 30. Epidemiologic perspectives of risk for developing diabetes and diabetes complications.
    Berry D; Melkus GD
    Nurs Clin North Am; 2006 Dec; 41(4):487-98, v. PubMed ID: 17059970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diabetes mellitus and hyperlipidemia].
    Toyota T
    Nihon Naika Gakkai Zasshi; 1992 Nov; 81(11):1737-8. PubMed ID: 1479211
    [No Abstract]   [Full Text] [Related]  

  • 32. [Aggressive control of cardiovascular risk factors].
    Abrignani MG; Sclavo M
    Ital Heart J; 2004 Apr; 5 Suppl 4():25S-32S. PubMed ID: 15185475
    [No Abstract]   [Full Text] [Related]  

  • 33. Sex disparity in the management of dyslipidemia among patients with type 2 diabetes mellitus in a managed care organization.
    Nau DP; Mallya U
    Am J Manag Care; 2005 Feb; 11(2):69-73. PubMed ID: 15726854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the increase in co-payments from 20 to 30 percent on the compliance rate of patients with hypertension or diabetes mellitus in the employed health insurance system.
    Babazono A; Miyazaki M; Imatoh T; Une H; Yamamoto E; Tsuda T; Tanaka K; Tanihara S
    Int J Technol Assess Health Care; 2005; 21(2):228-33. PubMed ID: 15921063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypertension and diabetes: role of the renin-angiotensin system.
    Jandeleit-Dahm K; Cooper ME
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):469-90, vii. PubMed ID: 16959581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Costs and consequences of ESRD in NC.
    Norman M; Young H; Bell RA
    N C Med J; 1997; 58(3):165. PubMed ID: 9164124
    [No Abstract]   [Full Text] [Related]  

  • 37. [Overview of the most important studies of hypertension and diabetes mellitus].
    Spinar J; Vítovec J
    Vnitr Lek; 1999 Nov; 45(11):677-9. PubMed ID: 10951862
    [No Abstract]   [Full Text] [Related]  

  • 38. Health behavior among patients with type 1 and 2 diabetes mellitus as reported from a regional diabetic outpatient department.
    Opalińska E; Strzemecka J; Latalski M; Goniewicz M
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):64-70. PubMed ID: 15323168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR).
    Gudbjörnsdottir S; Eeg-Olofsson K; Cederholm J; Zethelius B; Eliasson B; Nilsson PM;
    Diabet Med; 2009 Jan; 26(1):53-60. PubMed ID: 19125761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.